Overview

A Study of TYRA-300 in Children With Achondroplasia: BEACH301

Status:
RECRUITING
Trial end date:
2030-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and identify potentially effective dose(s) of TYRA-300 in children with achondroplasia with open growth plates.
Phase:
PHASE2
Details
Lead Sponsor:
Tyra Biosciences, Inc